Significantly more patients in the bevacizumab group achieved a pathological complete response compared with those treated with chemotherapy alone : @ ( @ % , @ % CI @-@ ) of @ patients in the Bev + D-FEC group compared with @ ( @ % , @-@ ) of @ patients in the D-FEC group ( p = @ ) .